Return to Today's science sparks archives

2015-10-01

Fig 1. Recurrent CDKN1B mutations in classical HCL.

Fig 1. Recurrent CDKN1B mutations in classical HCL.
  • Dietrich S, Hüllein J, Lee SC, Hutter B, Gonzalez D, Jayne S, Dyer MJ, Oleś M, Else M, Liu X, Słabicki M, Wu B, Troussard X, Dürig J, Andrulis M, Dearden C, von Kalle C, Granzow M, Jauch A, Fröhling S, Huber W, Meggendorfer M, Haferlach T, Ho AD, Richter D, Brors B, Glimm H, Matutes E, Abdel Wahab O, Zenz T

  • Blood. 2015 Aug 20;126(8):1005-8.

2015-10-02

Fig 1. PARP1 immunofluorescence staining of brain, U251 MG xenografts, and U87 MG xenografts.

Fig 1. PARP1 immunofluorescence staining of brain, U251 MG xenografts, and U87 MG xenografts.
  • Salinas B, Irwin CP, Kossatz S, Bolaender A, Chiosis G, Pillarsetty N, Weber WA, Reiner T

  • EJNMMI Res. 2015 Dec;5(1):123.
Open Access button

2015-10-05

Fig 2. GCN2 phosphorylates eIF2α during mitochondrial dysfunction.

Fig 2. GCN2 phosphorylates eIF2α during mitochondrial dysfunction.
  • Schulz AM, Haynes CM

  • Biochim Biophys Acta. 2015 Nov;1847(11):1448-56.

2015-10-06

Fig 1. Experimental approach.

Fig 1. Experimental approach.
  • Rodić N, Steranka JP, Makohon-Moore A, Moyer A, Shen P, Sharma R, Kohutek ZA, Huang CR, Ahn D, Mita P, Taylor MS, Barker NJ, Hruban RH, Iacobuzio-Donahue CA, Boeke JD, Burns KH

  • Nat Med. 2015 Sep;21(9):1060-4.

2015-10-07

Fig 2. Mutations detected by targeted sequencing and shared by at least 30% of DMs. The columns denote the samples (according to Table 1), the rows refer to the genes, and the green squares indicate mutations.

Fig 2. Mutations detected by targeted sequencing and shared by at least 30% of DMs. The columns denote the samples (according to Table 1), the rows refer to the genes, and the green squares indicate mutations.
  • Wiesner T, Kiuru M, Scott SN, Arcila M, Halpern AC, Hollmann T, Berger MF, Busam KJ

  • Am J Surg Pathol. 2015 Oct;39(10):1357-62.

2015-10-08

Fig 1. Nomogram.

Fig 1. Nomogram.
  • Groot Koerkamp B, Wiggers JK, Gonen M, Doussot A, Allen PJ, Besselink MG, Blumgart LH, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR

  • Ann Oncol. 2015 Sep;26(9):1930-5

2015-10-09

Fig 1. An H&E stained section of mucosal rolls procured using our “rolling technique” showing a well preserved mucosa layer delineated by the muscularis mucosae at its base.

Fig 1. An H&E stained section of mucosal rolls procured using our “rolling technique” showing a well preserved mucosa layer delineated by the muscularis mucosae at its base.
  • Shia J, Stadler ZK, Weiser MR, Vakiani E, Mendelsohn R, Markowitz AJ, Shike M, Boland CR, Klimstra DS

  • Fam Cancer. 2015 Mar;14(1):61-8.

2015-10-12

Fig 2. Apoptotic membrane blebbing through the DR5/Casp-3/ROCK1 signaling pathway.

Fig 2. Apoptotic membrane blebbing through the DR5/Casp-3/ROCK1 signaling pathway.
  • Forero-Torres A, Varley KE, Abramson VG, Li Y, Vaklavas C, Lin NU, Liu MC, Rugo HS, Nanda R, Storniolo AM, Traina TA, Patil S, Van Poznak CH, Nangia JR, Irvin WJ Jr, Krontiras H, De Los Santos JF, Haluska P, Grizzle W, Myers RM, Wolff AC; Translational Breast Cancer Research Consortium (TBCRC).

  • Clin Cancer Res. 2015 Jun 15;21(12):2722-9.

2015-10-13

Fig 2. Example of changes in spleen volume after 6 months of chemotherapy.

Fig 2. Example of changes in spleen volume after 6 months of chemotherapy.
  • Joiner BJ, Simpson AL, Leal JN, D'Angelica MI, Do RK

  • Abdom Imaging. 2015 Oct;40(7):2338-44.

2015-10-14

Figure 3. Docked complexes of 7 and MOR (A); 7 and DOR (B).

Figure 3. Docked complexes of 7 and MOR (A); 7 and DOR (B).
  • Váradi A, Palmer TC, Haselton N, Afonin D, Subrath JJ, Le Rouzic V, Hunkele A, Pasternak GW, Marrone GF, Borics A, Majumdar S

  • ACS Chem Neurosci. 2015 Sep 16;6(9):1570-7.

2015-10-15

Fig 1. Near-infrared fluorescence hyperspectral microscope.

Fig 1. Near-infrared fluorescence hyperspectral microscope.
  • Roxbury D, Jena PV, Williams RM, Enyedi B, Niethammer P, Marcet S, Verhaegen M, Blais-Ouellette S, Heller DA

  • Sci Rep. 2015 Sept 21: 1-6.
Open Access button

2015-10-16

Fig 1. The role of FANCM and partner proteins in coping with template lesions during DNA replication.

Fig 1. The role of FANCM and partner proteins in coping with template lesions during DNA replication.
  • Xue X, Sung P, Zhao X

  • Genes Dev. 2015 Sep 1;29(17):1777-88.

2015-10-19

Fig 2. AID Contributes to Epigenetic Diversity within GCB.

Fig 2. AID Contributes to Epigenetic Diversity within GCB.
  • Dominguez PM, Teater M, Chambwe N, Kormaksson M, Redmond D, Ishii J, Vuong B, Chaudhuri J, Melnick A, Vasanthakumar A, Godley LA, Papavasiliou FN, Elemento O, Shaknovich R

  • Cell Rep. 2015 Sep 29;12(12):2086-98.
Open Access button

2015-10-20

Fig 1. PTPRD mutations are common in HNSCC and other cancers.

Fig 1. PTPRD mutations are common in HNSCC and other cancers.
  • Peyser ND, Du Y, Li H, Lui V, Xiao X, Chan TA, Grandis JR

  • PLoS One. 2015 Aug 12;10(8):e0135750.
Open Access button

2015-10-21

Fig 4. DNAppG primer extension by mammalian polymerase β.

Fig 4. DNAppG primer extension by mammalian polymerase β.
  • Chauleau M, Das U, Shuman, S

  • Nucl. Acids Res. 2015 March 31; 43(6): 3197-3207.
Open Access button

2015-10-22

Fig 1. (A) Organoaxial volvulus occurs when the stomach rotates along its long axis, placing the greater curvature anteriorly and the lesser curvature posteriorly. (B) Mesenteroaxial volvulus occurs when the stomach rotates along its short axis placing the antrum anteriorly and superiorly.

Fig 1. (A) Organoaxial volvulus occurs when the stomach rotates along its long axis, placing the greater curvature anteriorly and the lesser curvature posteriorly. (B) Mesenteroaxial volvulus occurs when the stomach rotates along its short axis placing the antrum anteriorly and superiorly.
  • Farber BA, Lim IIP, Murphy JM, Price AP, Abramson SJ, La Quaglia MP

  • J Ped Surg Case Reports. 2015; 3: 447-450.
Open Access button

2015-10-23

Fig 1. T cell activation and recruitment to tumor cells.

Fig 1. T cell activation and recruitment to tumor cells.
  • Roberts SS, Chou AJ, Cheung NK

  • Front Oncol. 2015 Aug 7;5:181.
Open Access button

2015-10-26

Fig 1. Examples of susceptibility artifacts for common percutaneous devices when placed perpendicular to 1.5-T main magnetic field.

Fig 1. Examples of susceptibility artifacts for common percutaneous devices when placed perpendicular to 1.5-T main magnetic field.
  • Kaye EA, Granlund KL, Morris EA, Maybody M, Solomon SB

  • AJR Am J Roentgenol. 2015 Oct;205(4):W400-1.

2015-10-27

Fig 2. A 64-year-old female patient with recurrent ovarian cancer.

Fig 2. A 64-year-old female patient with recurrent ovarian cancer.
  • Vargas HA, Burger IA, Goldman DA, Miccò M, Sosa RE, Weber W, Chi DS, Hricak H, Sala E

  • Eur Radiol. 2015 Nov;25(11):3348-53.

2015-10-28

Fig 1. The pos-1 Gutless Phenotype Is Suppressed by neg-1 Loss of Function.

Fig 1. The pos-1 Gutless Phenotype Is Suppressed by neg-1 Loss of Function.
  • Elewa A, Shirayama M, Kaymak E, Harrison PF, Powell DR, Du Z, Chute CD, Woolf H, Yi D, Ishidate T, Srinivasan J, Bao Z, Beilharz TH, Ryder SP, Mello CC

  • Dev Cell. 2015 Jul 6;34(1):108-18.

2015-10-29

Fig 2. A working model summarizing the pathophysiology of bone marrow fibrosis in primary myelofibrosis.

Fig 2. A working model summarizing the pathophysiology of bone marrow fibrosis in primary myelofibrosis.
  • Nazha A, Khoury JD, Rampal RK, Daver N

  • Oncologist. 2015 Oct;20(10):1154-60.

2015-10-30

Fig 7. Interactions of Vis with M6 and NAD+.

Fig 7. Interactions of Vis with M6 and NAD+.
  • Ravulapalli R, Lugo MR, Pfoh R, Visschedyk D, Poole A, Fieldhouse RJ, Pai EF, Merrill AR

  • Biochemistry. 2015 Sep 29;54(38):5920-36.